Katherine Redman

Statistics

Publications

Citations

H-Index

Active since

2011

Affiliations

Katherine Redman is an author at Dana-Farber Cancer Institute specializing in hematologic oncology, hematologic malignancy therapy, and multiple myeloma therapy.

Publications per year

2011–2012

Publications

An Overview of the VISTA Trial: Newly Diagnosed, Untreated Patients with Multiple Myeloma Ineligible for Stem Cell Transplantation

Ivan Špıčka, MV Mateos, Katherine Redman et al. · Immunotherapy · 2011 · 14 citations

Medicine, Oncology, Pharmacotherapy +15

The potential benefits of participating in early‐phase clinical trials in multiple myeloma: long‐term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomib

Paul G. Richardson, Jacob P. Laubach, Robert Schlossman et al. · European Journal Of Haematology · 2012 · 11 citations

Medicine, Hematology, Pharmacotherapy +15

1–2 of 2